Aclaris Therapeutics Inc — Cash Flow (NASDAQ:ACRS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 38.63 M52.13 M67.57 M78.33 M20.07 M47.11 M 47.11 M Cash from investing activities 6.39 M167.63 M12.63 M46.22 M69.77 M48.37 M 48.37 M Cash from financing activities 18.37 M225.05 M72.87 M26.71 M74.54 M5.86 M 5.86 M Free cash flow 38.18 M51.83 M66.96 M77.02 M-15.86 M47 M 46.17 M

新闻

Stifel повысил целевую цену акций Aclaris Therapeutics до $3

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris Therapeutics Inc: доходы, прибыль оказались ниже прогнозов в Q4

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris начинает исследование фазы 1b препарата ATI-052 у пациентов с астмой

Aclaris starts phase 1b trial of ATI-052 in asthma patients

Craig-Hallum начинает покрытие акций Aclaris Therapeutics с рейтингом "Покупать"

Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating

H.C. Wainwright подтверждает рейтинг "покупать" для Aclaris после успешных результатов